SeaStar Medical Holding Corp financial data

Symbol
ICU, ICUCW on Nasdaq
Location
3513 Brighton Blvd, Suite 410, Denver, CO
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 13, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 85.4 % +211%
Quick Ratio 0.47 %
Debt-to-equity -7.77K % -5380%
Return On Equity 17.8K % +5541%
Return On Assets -233 % +69.3%
Operating Margin -1.93K %

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 27.9M shares +767%
Common Stock, Shares, Outstanding 17.3M shares +811%
Entity Public Float 23.9M USD
Common Stock, Value, Issued 2K USD +100%
Weighted Average Number of Shares Outstanding, Basic 11.3M shares +259%
Weighted Average Number of Shares Outstanding, Diluted 11.3M shares +259%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 766K USD
Research and Development Expense 8.54M USD +35.7%
General and Administrative Expense 7M USD -14.7%
Operating Income (Loss) -14.8M USD -2.09%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -14.7M USD +55%
Income Tax Expense (Benefit) 3K USD -100%
Net Income (Loss) Attributable to Parent -14.7M USD +55%
Earnings Per Share, Basic -1 USD/shares +95.3%
Earnings Per Share, Diluted -1 USD/shares +95.3%

Balance Sheet

Label TTM Value / Value Unit Change %
Accounts Receivable, after Allowance for Credit Loss, Current 217K USD
Inventory, Net 77K USD
Assets, Current 7.65M USD +217%
Assets 8.38M USD +142%
Accounts Payable, Current 3.16M USD -23.3%
Accrued Liabilities, Current 1.88M USD -16.6%
Contract with Customer, Liability, Current 0 USD -100%
Liabilities, Current 5.04M USD -49.2%
Contract with Customer, Liability, Noncurrent 438K USD
Liabilities 5.04M USD -51.4%
Retained Earnings (Accumulated Deficit) -145M USD -11.2%
Stockholders' Equity Attributable to Parent 3.34M USD
Liabilities and Equity 8.38M USD +142%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities -2.65M USD +23.9%
Net Cash Provided by (Used in) Financing Activities 6.13M USD -26.4%
Common Stock, Shares Authorized 450M shares -10%
Common Stock, Shares, Issued 17.3M shares +438%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 6.3M USD +435%
Interest Paid, Excluding Capitalized Interest, Operating Activities 0 USD -100%
Deferred Tax Assets, Valuation Allowance 28.5M USD +11.4%
Deferred Tax Assets, Gross 28.5M USD +11.4%
Deferred Tax Assets, Operating Loss Carryforwards 23.9M USD +9.24%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Unrecognized Tax Benefits 944K USD +758%
Additional Paid in Capital 149M USD +20.1%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 677K USD +137%
Interest Expense 39K USD -94%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%